Simplex Trading
XGN icon

Simplex Trading’s Exagen XGN Stock Holding History

Simplex Trading’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-81
Closed -$306 – 9854
2024
Q4 		$0 Sell
81
-473
-85% -$1.7K ﹤0.01% 9785
2024
Q3 		$1K Sell
554
-80
-13% -$207 ﹤0.01% 8308
2024
Q2 		$1K Buy
+634
New +$1.07K ﹤0.01% 8592
2023
Q2 		– Sell
-235
Closed – – 10094
2023
Q1 		$0 Sell
235
-312
-57% -$807 ﹤0.01% 10286
2022
Q4 		$1K Buy
+547
New +$1.4K ﹤0.01% 8959
2022
Q1 		– Sell
-12
Closed -$103 – 11530
2021
Q4 		$0 Buy
+12
New +$141 ﹤0.01% 11601

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Simplex Trading's XGN Position: Q1 2025 in Review

Simplex Trading sold out of Exagen (XGN) in Q1 2025, closing a stake of 81 shares — an estimated $306 sold.

Simplex Trading first reported a position in XGN in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q3 2024. 38 funds tracked by Wall St. Rank hold XGN as of Q1 2025.

  • Simplex Trading reported no remaining Exagen position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 81 Exagen shares in Q1 2025, an estimated $306.
  • Simplex Trading first reported a position in Exagen in Q4 2021 and held it in 6 quarters.
  • Simplex Trading's Exagen position peaked at $1K in Q3 2024.
  • 38 funds tracked by Wall St. Rank held Exagen as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.